Effects of Multidomain Training of Health With Aging (Train-Old)
Train-Old
Psycho-physiological Effects of Multidomain Training in Adults and Older Adults
1 other identifier
interventional
80
1 country
1
Brief Summary
The current study aims to determine the effect of a multidomain intervention (physical fitness, motivational and cognitive training) on body composition, sarcopenia, cardiovascular health, physical fitness, functional capacity, quality of life, frailty, emotional state and cognitive status in elderly participants, through a randomized controlled trial, to determine its suitability and recommend it as a preventive and health strategy for community-dwelling older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2022
CompletedStudy Start
First participant enrolled
July 28, 2022
CompletedFirst Posted
Study publicly available on registry
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedAugust 2, 2022
July 1, 2022
2 months
July 28, 2022
July 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Body Weight in Kilograms
was measured after removal of shoes and heavy outer clothing, using a Tanita BC-418 MA or InBody equipment to the nearest 0.1 kg.
Change from Baseline body weight (kg) at 18 weeks
Height in Meters
Standing height without shoes was measured using a Seca 202 stadiometer (Seca, Hamburg, Germany) to the nearest 0.1 cm.
Change from Baseline standing height (cm) at 18 weeks
Body Mass Index (BMI)
was calculated as the ratio of weight to squared height in kg/m\^2
Change from Baseline Body Mass Index (BMI): (kg/m^2) at 18 weeks
% Fat Mass
% fat mass was measured after removal of shoes and heavy outer clothing, using a Tanita BC-418 MA or InBody equipment to the nearest 0.1 kg.
Change from Baseline bioelectrical impedance % fat mass at 18 weeks
Muscle quality sarcopenia
Sarcopenia will be assessed taking into account the reference values established for muscle quality. The muscle quality will be measure by hand grip strength test. This test will be performance with manual dynamometry (TKK 5401; Scientific Instruments Co., Ltd., Tokyo, Japan). Maximal isometric upper limb strength will be performance by maximal isometric strength. Upper strength will be register by kilogrammes. Higher value show high strength.
Change from Baseline to 18 weeks
Secondary Outcomes (16)
Change Blood pressure
Change from Baseline to 18 weeks
Change Chair stand test
Change from Baseline to 18 weeks
Change Upper and Lower strength
Change from Baseline to 18 weeks
Health-related quality
Change from Baseline to 18 weeks
Cardiorrespiratory 6 minutes walk test
Change from Baseline to 18 weeks
- +11 more secondary outcomes
Study Arms (2)
Multidomain training group
EXPERIMENTALParticipants will use free weights and functional materials to work the main muscle groups. In addition, they will perform cardiorespiratory training and cognitive training with proposed tasks. Participants will follow the planned training progression. The researchers will record the number of sets completed and the load lifted for each exercise for each participant and the perception of effort in each class.
Control group
NO INTERVENTIONThe control group did not receive a training program and were asked not to modify their physical activity habits.
Interventions
The training program has a duration of 18 weeks with 2 training sessions per week. The training will have a gradual progression of intensity. One day they train two blocks of strength and one block of cognitive exercises and on the second day, they train one block of power, one block of strength+cognitive and one block of aerobic training. All sessions are 60 minutes long (10 minutes of warm-up, 40 minutes of training and 10 minutes of cool-down). Classes are in small groups of no more than 8 members.
Eligibility Criteria
You may qualify if:
- Subject has provided written and dated informed consent to participate in the study.
- Subject is a male or female between 55 and 90 years of age, inclusive.
- Subject is in good health as determined by a health history questionnaire and has been provided clearance from their personal physician.
- Subject is untrained in resistance and aerobic exercise (does not participate in structured physical activity, including walking, more than 3 times per week).
- Ability to walk independently without any gait aid
You may not qualify if:
- Perform high-intensity aerobic exercise on a consistent basis (\>180 min-week).
- Be performing some other regular and systematic strength training program during the intervention in the first half of 2022.
- Have a body mass index greater than 35.
- Have a diagnosis of ischemic heart disease.
- Have a diagnosis of severe aortic stenosis, uncontrolled arrhythmias, decompensated heart failure or acute myocarditis.
- Possess uncontrolled blood pressure (TAS \>180 and TAD \>110).
- Stroke.
- Severe peripheral arterial disease.
- Other illnesses such as recent thromboembolic disease, aortic aneurysm, clinically significant renal or hepatic insufficiency, severe COPD, clinically significant acute infections, severe psychiatric illness, uncontrolled metabolic disease, limiting locomotor pathology or musculoskeletal disease worsened by exercise, hormone therapy at the time or one year prior, being a woman with surgical menopause.
- Other pathologies that contraindicate the practice of physical exercise, collected in the previous medical examination that all participants must undergo.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pablo Jorge Marcos Pardo
AlmerÃa, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pablo Jorge Marcos Pardo, PhD
Universidad de Almeria
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 28, 2022
First Posted
August 1, 2022
Study Start
July 28, 2022
Primary Completion
September 18, 2022
Study Completion
December 30, 2022
Last Updated
August 2, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share
Once the data are published, the data can be requested and will be made available to other researchers.